Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Spes Medica srl
WARNING LETTER
•Spes Medica srl•October 4, 2012

Spes Medica srl – FDA Warning Letter, Oct 4, 2012

Record Details

The FDA issued a Warning Letter to Spes Medica Srl following an inspection from October 1-4, 2012, in Battipaglia, Italy, which found their Electromyography Needles to be adulterated under 21 U.S.C. § 351(h) due to non-conformity with the Quality System regulation (21 CFR Part 820). The firm's November 1, 2012, response to the FDA 483 observations was largely deemed inadequate. Key violations include failures in design change procedures (21 CFR 820.30(i)), maintaining Device Master Records (21 CFR 820.181), controlling environmental conditions (21 CFR 820.70(c)), documenting Corrective and Preventive Actions (21 CFR 820.100(b)), establishing equipment maintenance schedules (21 CFR 820.70(g)(1)), maintaining Device History Records (21 CFR 820.184(e)), and conducting independent quality audits (21 CFR 820.22). The FDA noted that the firm's proposed corrective actions often lacked retrospective reviews, personnel training, or complete documentation. Spes Medica Srl must provide a written response within fifteen business days detailing specific corrective and preventive actions, including systemic changes and a timetable for completion, with English translations of all documentation. Failure to address these issues could impact federal contracts, premarket approvals, and Certificates to Foreign Governments, indicating serious systemic problems requiring thorough investigation.

Company
Spes Medica srl
Inspection date
October 4, 2012
Product type
Devices
Office
Center for Devices and Radiological Health
Person
  • Steven D. Silverman (President)
View Company Profile

ID · 2f90166c-c2da-40e0-a68f-e841f8d25bf4

Violation Codes9
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 820.30(i)21 CFR 820.18121 CFR 820.70(c)21 CFR 820.100(b)21 CFR 820.70(g)(1)21 CFR 820.18421 CFR 820.22

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Spes Medica srl
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.